NCT01837316View on ClinicalTrials.gov

A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 21, 2013

Primary Completion Date

August 8, 2014

Study Completion Date

August 8, 2014

Conditions
Asthma
Interventions
DRUG

FF/VI 100/25 mcg

First strip: Fluticasone furoate inhalation powder blended with lactose, 100 mcg per blister

DRUG

Placebo

First strip: Inhalation powder of lactose

Trial Locations (1)

6021

GSK Investigational Site, Wellington

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01837316 - A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma | Biotech Hunter | Biotech Hunter